Can’t find what you’re looking for? Contact us.

Or, need help ordering? 805.528.4341

Filter Samples By:

Get Weekly Research Sample Updates in your Inbox:

Nonalcoholic steatohepatitis (NASH) Clinical Research Samples

Discovery Life Sciences provides the highest quality Nonalcoholic steatohepatitis (NASH) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All Nonalcoholic steatohepatitis (NASH) Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Showing 79 of 79 total samples
 (0)
Checkout
Advanced Data View:
Showing 79 of 79 total samples
Buy
Product IDSampleOriginMatrixVial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Detail 1Test 2Test Data 2Detail 2Test 3Test Data 3Detail 3Product
Details
Price
Buy
Blood TypeCo-morbiditiesConsent Status DateCurrent MedicationsIs PregnantBilirubinLaboratory ResultsRisk GroupEver developed JaundiceLiver BiopsyCirrhosis?Ascites?History of Renal Insufficiency?Initial Date of Disease DiagnosisCirrhosisAll Known Test Results Performed in Previous Six monthsAbbott Architect
BBS0000-AI900400837060820DDNonalcoholic steatohepatitis (NASH)United StatesSerum1.501.00$150.0060 YFemaleNon-Hispanic<-70C08-Jun-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate16 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate21 U/LAST$150.00Unknown0.6
BBS0000-CY900400672012120DDNonalcoholic steatohepatitis (NASH)United StatesSerum4.002.00$300.0049 YFemaleNon-Hispanic<-70C21-Jan-20Clinical DiagnosisNonalcoholic steatohepatitis (NASH)UltrasoundHepatic fatty infiltration and borderline hepatomegaly.31-Mar-17$300.00UnknownHypertension, Diabetes, Hypothyroidism, Hypercholesterolemia, Depression2020-01-21Lisinopril, Nitroglycerin, Fluoxetine, Metoprolol-Hydrochlorothiazide, Farxiga, Repatha, Synthroid, NorvascFalseALT: 118 U/L AST: 39 U/L Bilirubin (total): 0.8 mg/dL Cholesterol: 126 mg/dL Triglycerides: 139 mg/dL HDL: 39 mg/dL LDL: 59 mg/dL 4-Dec-2019Hyperlipidemia, Obesity, DiabetesNoYes on 18-May-2017 Severe steatosis with associated steatohepatitis stage of fibrosis 2 approaching 3NoNoNo
BBS0000-CY900400673012120DDNonalcoholic steatohepatitis (NASH)United StatesSerum3.752.00$300.0060 YMaleNon-Hispanic<-70C21-Jan-20Clinical DiagnosisNonalcoholic steatohepatitis (NASH)MRIMild fatty infiltration with no aggressive intrahepatic lesions.12-Dec-16$300.00UnknownDiabetes mellitus type 22020-01-21TrulicityFalseNoneDiabetesNoYes on 3-Jan-2017 Severe bridging fibrosis with evolving cirrhosis (stage 3 to 4)Yes 3-Jan-2017 Liver biopsyNoNo
BBS0000-CY900400674011620DDNonalcoholic steatohepatitis (NASH)United StatesSerum2.002.00$300.0044 YMaleNon-Hispanic<-70C16-Jan-20Clinical DiagnosisNonalcoholic steatohepatitis (NASH)CT ScanFatty Liver22-Oct-15$300.00UnknownHypertension, Diabetes type 2, Hypercholesterolemia2020-01-16Lisinopril, Metformin HCl, Hydrochlorothiazide, Insulin, FarxigaFalseNoneHyperlipidemia, Obesity, Diabetes, Metaboic SyndromeNoYes on 29-Mar-2019 Moderate steatosis, indeterminate for steatohepatitis with bridging fibrosis. Iron deposition (1 of 4). Portal inflammation.NoNoNo
BBS0005-CY900085551030218DDNonalcoholic steatohepatitis (NASH)Serum1.001.00$300.0061 YFemaleNon-Hispanic<-70C02-Mar-18Clinical DiagnosisNASHUltrasoundHepatic fatty infiltration.23-Feb-16$300.00UnknownHypertension, High cholesterol, Diabetes, ArthritisLovastatin, Montelukast sodium, Lisinopril, Metformin, ViibrydNoNo23-Feb-16NoALT: 75 U/L | AST: 46 U/L
30-Jan-18
EDP0000-AI900342858100919DDNonalcoholic steatohepatitis (NASH)K2 EDTA Plasma1.201.00$150.0053 YFemaleNon-Hispanic<-70C09-Oct-19Abbott Architect | Kinetic W/O Pyridoxal Phosphate34AST$150.00Unknown16 U/L
ALT
1.4
Bilirubin
EDP0000-AI900358876121319DDNonalcoholic steatohepatitis (NASH)K2 EDTA Plasma1.401.00$150.0065 YMaleNon-Hispanic<-70C13-Dec-19DiagnosisNASHAbbott Architect5 U/LALTAbbott Architect76 U/LAST$150.00Unknown4.4
EDP0000-AI900360897123019DDNonalcoholic steatohepatitis (NASH)K2 EDTA Plasma1.401.00$150.0048 YFemaleUnknown<-70C30-Dec-19DiagnosisNASH$150.00Unknown
EDP0000-AI900368143011120DDNonalcoholic steatohepatitis (NASH)K2 EDTA Plasma1.201.00$150.0080 YFemaleNon-Hispanic<-70C11-Jan-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate18 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate22 U/LAST$150.00Unknown0.8
EDP0000-AI900368144011320DDNonalcoholic steatohepatitis (NASH)K2 EDTA Plasma1.301.00$150.0060 YMaleNon-Hispanic<-70C13-Jan-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate17 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate21 U/LAST$150.00Unknown2.9
EDP0000-AI900368145012020DDNonalcoholic steatohepatitis (NASH)K2 EDTA Plasma1.001.00$150.0060 YFemaleNon-Hispanic<-70C20-Jan-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate14 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate26 U/LAST$150.00Unknown0.8
EDP0000-AI900371306020820DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.801.00$150.0056 YMaleNon-Hispanic<-70C08-Feb-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate6 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate24 U/LAST$150.00Unknown2.1
EDP0000-AI900374098020220DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.101.00$150.0085 YFemaleNon-Hispanic<-70C02-Feb-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate21 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate37 U/LAST$150.00Unknown
EDP0000-AI900374375021820DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.401.00$150.0076 YFemaleNon-Hispanic<-70C18-Feb-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate26 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate33 U/LAST$150.00Unknown0.9
EDP0000-AI900375324012720DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.301.00$150.0016 YMaleNon-Hispanic<-70C27-Jan-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate91 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate44 U/LAST$150.00Unknown0.05
EDP0000-AI900375325012720DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.401.00$150.0077 YMaleNon-Hispanic<-70C27-Jan-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate39 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate37 U/LAST$150.00Unknown0.9
EDP0000-AI900375326012720DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.301.00$150.0063 YFemaleNon-Hispanic<-70C27-Jan-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate44 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate29 U/LAST$150.00Unknown0.5
EDP0000-AI900375327011220DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.701.00$150.0068 YMaleNon-Hispanic<-70C12-Jan-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate76 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate90 U/LAST$150.00Unknown2.3
EDP0000-AI900377540021820DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.401.00$150.0053 YMaleNon-Hispanic<-70C18-Feb-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate50 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate33 U/LAST$150.00Unknown0.5
EDP0000-AI900383612031620DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.001.00$150.0041 YMaleNon-Hispanic<-70C16-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate36 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate29 U/LAST$150.00Unknown0.6
EDP0000-AI900384273030320DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.201.00$150.0073 YMaleNon-Hispanic<-70C03-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate63 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate52 U/LAST$150.00Unknown0.9
EDP0000-AI900384276031620DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.501.00$150.0060 YFemaleNon-Hispanic<-70C16-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate14 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate19 U/LAST$150.00Unknown0.6
EDP0000-AI900384335030520DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.001.00$150.00FemaleNon-Hispanic<-70C05-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate34 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate47 U/LAST$150.00Unknown1
EDP0000-AI900385007030220DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.001.00$150.0060 YFemaleNon-Hispanic<-70C02-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate14 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate22 U/LAST$150.00Unknown0.9
EDP0000-AI900385008022620DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.401.00$150.0060 YFemaleNon-Hispanic<-70C26-Feb-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate13 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate18 U/LAST$150.00Unknown0.6
EDP0000-AI900385706031220DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.201.00$150.0076 YFemaleNon-Hispanic<-70C12-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate15 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate28 U/LAST$150.00Unknown0.9
EDP0000-AI900388849032820DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.001.00$150.0068 YFemaleNon-Hispanic<-70C28-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate16 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate54 U/LAST$150.00Unknown
EDP0000-AI900397834042920DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.001.00$150.0083 YFemaleNon-Hispanic29-Apr-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate25 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate34 U/LAST$150.00Unknown2.4
EDP0000-AI900400839060220DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.001.00$150.0065 YFemaleNon-Hispanic<-70C02-Jun-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate15 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate15 U/LAST$150.00Unknown2.3
EDP0000-AI900401406052120DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma1.001.00$150.0071 YFemaleNon-Hispanic<-70C21-May-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate22 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate17 U/LAST$150.00Unknown
EDP0000-CY900085550031319DDNonalcoholic steatohepatitis (NASH)K2 EDTA Plasma1.002.00$300.0066 YFemaleNon-Hispanic<-70C13-Mar-19Clinical DiagnosisNASHUltrasoundHepatitic fatty infiltration. No small mass.21-Aug-17$300.00UnknownDiabetes, Hypertension, High cholesterolLovaza, Coreg, MetforminNoNoNo
EDP0000-CY900356515092019DDNonalcoholic steatohepatitis (NASH)K2 EDTA Plasma1.007.00$300.0028 YMaleHispanic<-70C20-Sep-19Clinical DiagnosisNonalcoholic steatohepatitis (NASH)UltrasoundHepatic fatty infiltration2016-01-12MRINo focal lesions identified1-Jul-14$300.00UnknownNone2019-09-20NoneFalseNoneObesityNoYes on 5-Feb-2014 | Severe steatosis with associated steatohepatitis, Fibrosis 1 approaching 2NoNoNo
EDP0000-CY900356554101119DDNonalcoholic steatohepatitis (NASH)K2 EDTA Plasma1.002.00$300.0057 YFemaleNon-Hispanic<-70C11-Oct-19Clinical DiagnosisNonalcoholic steatohepatitis (NASH)UltrasoundCholecystectomy without obvious cystitis in a patient with fatty liver.2011-02-25CTHepatic Steatosis25-Feb-11$300.00UnknownHyperlipidemia, IBS, Diabetes, Thyroid disease, GERD2019-10-11Lisinopril, Synthroid, Metformin, Pravastatin, Jublia, Ambien, Singulair, HydrochlorothiazideFalseALT: 120 U/L | AST: 90 U/L | Bilirubin (total): 0.7 mg/dL | 22-Jul-2019 | Cholesterol: 158 mg/dL | Triglycerides: 202 mg/dL | HDL: 39 mg/dL | LDL: 79 mg/dL | 24-Jun-2019Hyperlipidemia, Obesity, DiabetesNoYes on 3-Sep-2019 | Stage 2-3NoNoNo
EDP0000-CY900356555101119DDNonalcoholic steatohepatitis (NASH)K2 EDTA Plasma1.001.00$300.0044 YMaleNon-Hispanic<-70C11-Oct-19Clinical DiagnosisNonalcoholic steatohepatitis (NASH)UltrasoundHepatomegaly & Hepatic steatosis2018-01-09$300.00UnknownHypertension2019-10-11LosartanFalseALT: 58 U/L | AST: 32 U/L | Bilirubin (total): 1.6 mg/dL | Cholesterol: 166 mg/dL | Triglycerides: 420 mg/dL | HDL: 27 mg/dL | 24-Apr-2019ObesityNoYes on 2-Mar-2018 | Stage F1NoNoNo
EDP0000-CY900356657081419DDNonalcoholic steatohepatitis (NASH)K2 EDTA Plasma1.006.00$300.0066 YMaleNon-Hispanic<-70C14-Aug-19Clinical DiagnosisNonalcoholic steatohepatitis (NASH)CTSlightly nodular liver contour2018-04-30$300.00UnknownCoronary artery disease, Atrial fibrillation, Osteoarthritis, Hypertension2019-08-14Losartan potassium, MeloxicamFalseALT: 21 U/L | AST: 19 U/L | Bilirubin (total): 1.0 mg/dL | Cholesterol: 119 mg/dL | Triglycerides: 78 mg/dL | HDL: 39 mg/dL | LDL: 64 mg/dL | 7-Jun-2018Hyperlipidemia, Obesity, Metabolic syndromeNoYes on 6-Jun-2018 | Steatosis grade 2; Inflammation grade 1; Ballooning grade 1; Fibrosis stage 2NoNoNo
EDP0000-CY900400672012120DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma5.002.00$300.0049 YFemaleNon-Hispanic<-70C21-Jan-20Clinical DiagnosisNonalcoholic steatohepatitis (NASH)UltrasoundHepatic fatty infiltration and borderline hepatomegaly.31-Mar-17$300.00UnknownHypertension, Diabetes, Hypothyroidism, Hypercholesterolemia, Depression2020-01-21Lisinopril, Nitroglycerin, Fluoxetine, Metoprolol-Hydrochlorothiazide, Farxiga, Repatha, Synthroid, NorvascFalseALT: 118 U/L AST: 39 U/L Bilirubin (total): 0.8 mg/dL Cholesterol: 126 mg/dL Triglycerides: 139 mg/dL HDL: 39 mg/dL LDL: 59 mg/dL 4-Dec-2019Hyperlipidemia, Obesity, DiabetesNoYes on 18-May-2017 Severe steatosis with associated steatohepatitis stage of fibrosis 2 approaching 3NoNoNo
EDP0000-CY900400673012120DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma4.752.00$300.0060 YMaleNon-Hispanic<-70C21-Jan-20Clinical DiagnosisNonalcoholic steatohepatitis (NASH)MRIMild fatty infiltration with no aggressive intrahepatic lesions.12-Dec-16$300.00UnknownDiabetes mellitus type 22020-01-21TrulicityFalseNoneDiabetesNoYes on 3-Jan-2017 Severe bridging fibrosis with evolving cirrhosis (stage 3 to 4)Yes 3-Jan-2017 Liver biopsyNoNo
EDP0000-CY900400674011620DDNonalcoholic steatohepatitis (NASH)United StatesK2 EDTA Plasma3.752.00$300.0044 YMaleNon-Hispanic<-70C16-Jan-20Clinical DiagnosisNonalcoholic steatohepatitis (NASH)CT ScanFatty Liver22-Oct-15$300.00UnknownHypertension, Diabetes type 2, Hypercholesterolemia2020-01-16Lisinopril, Metformin HCl, Hydrochlorothiazide, Insulin, FarxigaFalseNoneHyperlipidemia, Obesity, Diabetes, Metaboic SyndromeNoYes on 29-Mar-2019 Moderate steatosis, indeterminate for steatohepatitis with bridging fibrosis. Iron deposition (1 of 4). Portal inflammation.NoNoNo
ETP0000-AI900398750040320DDNonalcoholic steatohepatitis (NASH)United StatesEDTA Plasma1.001.00$150.0068 YFemaleUnknown<-70C03-Apr-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate30 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate66 U/LAST$150.00Unknown1.2
LHP0000-AI900112774101819DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.001.00$150.0078 YFemaleNon-Hispanic<-70C18-Oct-19DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate17 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate22 U/LAST$150.00Unknown
LHP0000-AI900338335110219DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.201.00$150.0055 YFemaleNon-Hispanic<-70C02-Nov-19DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate1221 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate7755 U/LAST$150.00Unknown
LHP0000-AI900338336110719DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.201.00$150.0060 YFemaleUnknown<-70C07-Nov-19DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate27 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate23 U/LAST$150.00Unknown
LHP0000-AI900338337110619DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.401.00$150.0038 YMaleNon-Hispanic<-70C06-Nov-19DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate27 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate19 U/LAST$150.00Unknown
LHP0000-AI900338563110619DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.101.00$150.0075 YMaleNon-Hispanic<-70C06-Nov-19DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate94 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate160 U/LAST$150.00Unknown
LHP0000-AI900352958112219DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.701.00$150.0068 YFemaleNon-Hispanic<-70C22-Nov-19DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate14 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate18 U/LAST$150.00Unknown
LHP0000-AI900355310112719DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.101.00$150.0073 YFemaleNon-Hispanic<-70C27-Nov-19DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate39 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate58 U/LAST$150.00Unknown
LHP0000-AI900358599122019DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.301.00$150.0074 YFemaleNon-Hispanic<-70C20-Dec-19DiagnosisNASHAbbott Architect15 U/LALTAbbott Architect15 U/LAST$150.00Unknown0.9
LHP0000-AI900358601121719DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.301.00$150.0045 YMaleNon-Hispanic<-70C17-Dec-19DiagnosisNASHAbbott Architect41 U/LALTAbbott Architect152 U/LAST$150.00Unknown4.4
LHP0000-AI900358602121219DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.101.00$150.0062 YMaleNon-Hispanic<-70C12-Dec-19DiagnosisNASHAbbott Architect54 U/LALTAbbott Architect130 U/LAST$150.00Unknown13.4
LHP0000-AI900358603121319DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.201.00$150.0062 YMaleNon-Hispanic<-70C13-Dec-19DiagnosisNASHAbbott Architect6 U/LALTAbbott Architect130 U/LAST$150.00Unknown12.2
LHP0000-AI900358604121519DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.001.00$150.0065 YMaleNon-Hispanic<-70C15-Dec-19DiagnosisNASHAbbott Architect40 U/LALTAbbott Architect73 U/LAST$150.00Unknown6.6
LHP0000-AI900358605121619DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.201.00$150.0065 YMaleNon-Hispanic<-70C16-Dec-19DiagnosisNASHAbbott Architect67 U/LALTAbbott Architect35 U/LAST$150.00Unknown8.7
LHP0000-AI900360896122419DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.101.00$150.0048 YFemaleNon-Hispanic<-70C24-Dec-19DiagnosisNASH$150.00Unknown
LHP0000-AI900362723010320DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.501.00$150.00MaleNon-Hispanic<-70C03-Jan-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate48 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate61 U/LAST$150.00Unknown1.9
LHP0000-AI900368177011920DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.001.00$150.0034 YMaleNon-Hispanic<-70C19-Jan-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate48 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate88 U/LAST$150.00Unknown13.8
LHP0000-AI900368178011520DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.501.00$150.0049 YFemaleUnknown<-70C15-Jan-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate25 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate62 U/LAST$150.00Unknown2.1
LHP0000-AI900368179011020DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.201.00$150.0072 YFemaleNon-Hispanic<-70C10-Jan-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate18 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate25 U/LAST$150.00Unknown0.8
LHP0000-AI900371017020920DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.401.00$150.0061 YFemaleNon-Hispanic<-70C09-Feb-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate9 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate10 U/LAST$150.00Unknown0.7
LHP0000-AI900371343021220DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.701.00$150.0061 YFemaleNon-Hispanic<-70C12-Feb-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate6 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate22 U/LAST$150.00Unknown1.1
LHP0000-AI900372027013020DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.201.00$150.0082 YFemaleNon-Hispanic<-70C30-Jan-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate13 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate26 U/LAST$150.00Unknown2.9
LHP0000-AI900372892020320DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.401.00$150.0075 YFemaleNon-Hispanic<-70C03-Feb-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate15 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate48 U/LAST$150.00Unknown0.8
LHP0000-AI900374097020720DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.001.00$150.00FemaleNon-Hispanic<-70C07-Feb-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate29 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate12 U/LAST$150.00Unknown
LHP0000-AI900376778012320DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.801.00$150.0082 YFemaleNon-Hispanic<-70C23-Jan-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate14 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate34 U/LAST$150.00Unknown2.7
LHP0000-AI900384271021820DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.301.00$150.0053 YMaleNon-Hispanic<-70C18-Feb-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate34 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate39 U/LAST$150.00Unknown2.1
LHP0000-AI900384272022120DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.201.00$150.0031 YMaleNon-Hispanic<-70C21-Feb-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate50 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate29 U/LAST$150.00Unknown0.5
LHP0000-AI900384275031320DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.501.00$150.0068 YFemaleUnknown<-70C13-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate53 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate74 U/LAST$150.00Unknown1.3
LHP0000-AI900384277031620DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.001.00$150.0072 YFemaleNon-Hispanic<-70C16-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate30 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate43 U/LAST$150.00Unknown2.1
LHP0000-AI900384278031820DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.501.00$150.0072 YFemaleNon-Hispanic<-70C18-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate29 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate37 U/LAST$150.00Unknown1.6
LHP0000-AI900384333031720DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.501.00$150.0072 YFemaleNon-Hispanic<-70C17-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate25 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate32 U/LAST$150.00Unknown1.9
LHP0000-AI900384334030920DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.001.00$150.0068 YFemaleUnknown<-70C09-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate52 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate62 U/LAST$150.00Unknown1
LHP0000-AI900385707031620DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.301.00$150.0066 YMaleNon-Hispanic<-70C16-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate18 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate13 U/LAST$150.00Unknown1.5
LHP0000-AI900385725031120DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.301.00$150.0063 YFemaleNon-Hispanic<-70C11-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate62 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate46 U/LAST$150.00Unknown0.5
LHP0000-AI900385726031120DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.401.00$150.0077 YFemaleNon-Hispanic<-70C11-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate100 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate100 U/LAST$150.00Unknown2.7
LHP0000-AI900385728031320DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.301.00$150.0055 YFemaleNon-Hispanic<-70C13-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate52 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate23 U/LAST$150.00Unknown0.5
LHP0000-AI900388850030720DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.001.00$150.0054 YFemaleNon-Hispanic<-70C07-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate18 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate33 U/LAST$150.00Unknown
LHP0000-AI900388851032820DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma2.001.00$150.0074 YFemaleNon-Hispanic<-70C28-Mar-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate24 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate35 U/LAST$150.00Unknown
LHP0000-AI900396807040220DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.001.00$150.0077 YFemaleNon-Hispanic<-70C02-Apr-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate23 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate44 U/LAST$150.00Unknown1.7
LHP0000-AI900396819040320DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma2.001.00$150.0068 YFemaleUnknown<-70C03-Apr-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate30 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate66 U/LAST$150.00Unknown1.3
LHP0000-AI900400838060320DDNonalcoholic steatohepatitis (NASH)United StatesL. Heparin Plasma1.001.00$150.0077 YFemaleNon-Hispanic<-70C03-Jun-20DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate24 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate28 U/LAST$150.00Unknown0.6

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.